Increased expression of CD24 in nonmelanoma skin cancer

International Journal of Biological Markers

Volumn 27, Issue 4, 2012, Pages

  Miller, Ehud ^a   Shapira, Shiran ^a,b   Gur, Eyal ^a   Naumov, Inna ^a,b   Kazanov, Dina ^a   Leshem, David ^a   Barnea, Yoav ^a   Meshiach, Yaakov ^a   Gat, Andrea ^a   Sion, Daniel ^b   Arber, Nadir ^a,b   Kraus, Sarah ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Basal cell carcinoma (BCC); Biomarker; CD24; Nonmelanoma skin cancer (NMSC); Squamous cell carcinoma (SCC)

Indexed keywords

CD24 ANTIGEN;

AGED; ARTICLE; BASAL CELL CARCINOMA; BLOOD SAMPLING; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE EXPRESSION; GENOTYPING TECHNIQUE; HISTOPATHOLOGY; HUMAN; LEUKOCYTE; MALE; NON MELANOMA SKIN CANCER; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANTIGENS, CD24; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872867012     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/JBM.2012.9935     Document Type: Article

References (29)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069-80.
3. Schulze HJ, Cribier B, Requena L, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005; 152: 939-47.
4. World Health Organization. Ultraviolet radiation and the INTERSUN programme. Skin cancers. Available from: http://www.who.int/uv/faq/skincancer/en/index1.html
5. Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 2004; 140: 837-42.
6. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
7. National Cancer Institute. Cancer trends progress report - 2011/2012 update. Sun protection. Available from: http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2009&chid=91&coid=911
8. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1996; 1: 136-42.
9. Samarasinghe V, Madan V. Nonmelanoma skin cancer. J Cutan Aesthet Surg 2012; 5: 3-10.
10. Riker AI, Enkemann SA, Fodstad O, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008; 1: 13.
11. Marghoob AA, Swindle LD, Moricz CZ, et al. Instruments and new technologies for the in vivo diagnosis of melanoma. J Acad Dermatol 2003; 49: 777-97.
12. Kay R, Takei F, Humphries RK. Expression cloning of a cDNA encoding M1/69-J11d heat-stable antigens. J Immunol 1990; 145: 1952-9.
13. Wenger RH, Ayane M, Bose R, Köhler G, Nielsen PJ. The genes for a mouse hematopoietic differentiation marker called the heat-stable antigen. Eur J Immunol 1991; 21: 1039-46.
14. Kristiansen G, Sammar M, Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 2004; 35: 255-62.
15. Ohl C, Albach C, Altevogt P, Schmitz B. N-glycosylation patterns of HSA/CD24 from different cell lines and brain homogenates: a comparison. Biochimie 2003; 85: 565-73.
16. Lim SC, Oh SH. The role of CD24 in various human epithelial neoplasias. Pathol Res Pract 2005; 201: 479-86.
17. Sagiv E, Arber N. The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy. Expert Rev Gastroenterol Hepatol 2008; 2: 125-33.
18. Poncet C, Frances V, Gristina R, Scheiner C, Pellissier JF, Figarella-Branger D. CD24, a glycosylphosphatidylinositolanchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors. Acta Neuropathol 1996; 91: 400-8.
19. Weber E, Schmitter D, Resch H, et al. Radiation studies on B cell differentiation marker CD24/SCLC Cluster-4 antigen expressing and non-expressing lung cancer cell lines and mouse fibroblasts. Int J Radiat Biol 1995; 68: 205-13.
20. Zarn JA, Zimmermann SM, Pass MK, Waibel R, Stahel RA. Association of CD24 with the kinase c-fgr in a small cell lung cancer cell line and with the kinase lyn in an erythroleukemia cell line. Biochem Biophys Res Commun 1996; 225: 384-91.
21. Jacob J, Bellach J, Grützmann R, et al. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology 2004; 4: 454-60.
22. Sagiv E, Memeo L, Karin A, et al. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 2006; 131: 630-9.
23. Redondo P, Garcia-Foncillas J, Okroujnov I, de Felipe I, Quintanilla E. CD24 Expression on human keratinocytes. Exp Dermatol 1998; 7: 175-8.
24. Deichmann M, Kurzen H, Enger U, Altevogt P, Hartschuh W. Adhesion molecules CD171 (LICAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas). J Cutan Pathol 2003; 30: 363-8.
25. Magnaldo T, Barrandon Y. CD24 (heat stable antigen, nectadrin), a novel keratinocyte differentiation marker, is preferentially expressed in areas of the hair follicle containing the colony-forming cells. J Cell Sci 1996; 109: 3035-45.
26. Zhou Q, Rammohan K, Lin S, et al. CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci U S A 2003; 100: 15041-6.
27. Sánchez E, Fernández-Gutierrez B, González-Gay MA, et al. Investigating the role of CD24 gene polymorphisms in rheumatoid arthritis. Ann Rheum Dis 2008; 67: 1197-8.
28. Wolff T, Tai E, Miller T. Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 150: 194-8.
29. Carroll DM, Billingsley EM, Helm KF. Diagnosing basal cell carcinoma by dermatoscopy. J Cutan Med Surg 1998; 3: 62-7.